{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T19:10:08Z","timestamp":1650136208540},"reference-count":8,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/naika.102.2370","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T23:18:00Z","timestamp":1410304680000},"page":"2370-2374","source":"Crossref","is-referenced-by-count":0,"title":["3. Molecular Pathogenesis of Leukemia"],"prefix":"10.2169","volume":"102","author":[{"given":"Mineo","family":"Kurokawa","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1) Dohner K, et al: Leukemias: diagnosis and classifications. Young NS, et al, eds. Clinical Hematology, Mosby Elsevier, 2006, 348-358."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Speck NA, Gilliland DG: Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2: 502-513, 2002.","DOI":"10.1038\/nrc840"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Schnittger S, et al: Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100: 59-66, 2002.","DOI":"10.1182\/blood.V100.1.59"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Falini B, et al: Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352: 254-266, 2005.","DOI":"10.1056\/NEJMoa041974"},{"key":"5","unstructured":"5) Ley TJ, et al: DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363: 2424-2433, 2010."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Delhommeau F, et al: Mutation in TET2 in myeloid cancers. N Engl J Med 363: 2289-2301, 2009.","DOI":"10.1056\/NEJMoa0810069"},{"key":"7","unstructured":"7) Mardis ER, et al: Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361: 1058-1066, 2009."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Moorman AV, et al: Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL):analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109: 3189-3197, 2007.","DOI":"10.1182\/blood-2006-10-051912"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/9\/102_2370\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T18:33:04Z","timestamp":1650133984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/9\/102_2370\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.102.2370","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}